EU approves two new antibody treatments

By Annette Birschel and Ella Joyner, Dpa
Updated November 11 2021 - 6:55pm, first published 6:53pm
The EMA has endorsed the use of Celltrion's Regkirona, made from regdanvimab, for all adults.

Two antibody therapy medications to combat COVID-19 have won approval from the European Medicines Agency (EMA), the body has announced.



Get the latest Wagga Wagga news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.